Related references
Note: Only part of the references are listed.Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review
Eline van Overbeeke et al.
DRUG DISCOVERY TODAY (2019)
Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review
Vikas Soekhai et al.
DRUG DISCOVERY TODAY (2019)
PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCES
Kevin Marsh et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2018)
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers
Anne M. Wolka et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2018)
Patient-centered clinical trials
Shomesh E. Chaudhuri et al.
DRUG DISCOVERY TODAY (2018)
A Randomized Clinical Trial Comparing the ELLIPTA and HandiHaler Dry Powder Inhalers in Patients With COPD: Inhaler-Specific Attributes and Overall Patient Preference
Kathryn A. Collison et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Is it worth it? Patient and public views on the impact of their involvement in health research and its assessment: a UK-based qualitative interview study
Joanna C. Crocker et al.
HEALTH EXPECTATIONS (2017)
Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients
Kevin Marsh et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2017)
TAKING PATIENT HETEROGENEITY AND PREFERENCES INTO ACCOUNT IN HEALTH TECHNOLOGY ASSESSMENTS
Wietske Kievit et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2017)
PATIENT-CENTERED BENEFIT-RISK ASSESSMENT IN DUCHENNE MUSCULAR DYSTROPHY
Ilene L. Hollin et al.
MUSCLE & NERVE (2017)
MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment
Tommi Tervonen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences
Lill-Brith von Arx et al.
VALUE IN HEALTH (2017)
Identifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment
Eugena Stamuli et al.
JOURNAL OF FOOT AND ANKLE RESEARCH (2017)
Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment
Ellen M. Janssen et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?
Ellen M. Janssen et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment
Axel C. Muehlbacher et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2017)
Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy
David John Mott et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2016)
Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA
Axel C. Muehlbacher et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2016)
Incorporating Patient Preferences Into Drug Development and Regulatory Decision Making: Results From a Quantitative Pilot Study With Cancer Patients, Carers, and Regulators
D. Postmus et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization
Meredith Y. Smith et al.
DRUG SAFETY (2016)
How to integrate research evidence on patient preferences in pharmaceutical coverage decisions and clinical practice guidelines: A qualitative study among Dutch stakeholders
Cecile M. A. Utens et al.
HEALTH POLICY (2016)
PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FORACTION
Julia Abelson et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2016)
A systematic review on methods used to evaluate patient preferences in psoriasis treatments
M. Gutknecht et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers
T. Morel et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
A Systematic Review of Health Economic Evaluation Studies Using the Patient's Perspective
Bik-Wai Bilvick Tai et al.
VALUE IN HEALTH (2016)
Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective
Axel C. Muehlbacher et al.
VALUE IN HEALTH (2016)
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies
Martin Ho et al.
VALUE IN HEALTH (2016)
Increasing Patient Involvement in Drug Development
Maria M. Lowe et al.
VALUE IN HEALTH (2016)
Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective
F. Reed Johnson et al.
VALUE IN HEALTH (2016)
Preference for pharmaceutical formulation and treatment process attributes
Katie D. Stewart et al.
Patient Preference and Adherence (2016)
Importance of hemodialysis-related outcomes: comparison of ratings by a self-help group, clinicians, and health technology assessment authors with those by a large reference group of patients
Inger M. Janssen et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Incorporating Patient Preferences into Medical Device Benefit-Risk Assessments
Telba Irony et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2016)
What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study
Suzanne Parsons et al.
BMJ OPEN (2016)
Value Based Care and Patient-Centered Care: Divergent or Complementary?
Eric K. Tseng et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2016)
What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences
Axel Muehlbacher et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Understanding drug preferences, different perspectives
Peter G. M. Mol et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Estimating Preferences for Treatments in Patients With Localized Prostate Cancer
Monica Avila et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Incorporating patient-preference evidence into regulatory decision making
Martin P. Ho et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2015)
Patient-centric HTA: different strokes for different folks
Axel C. Muehlbacher
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2015)
Identifying the Benefits and Risks of Emerging Treatments for Idiopathic Pulmonary Fibrosis: A Qualitative Study
John F. P. Bridges et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2015)
Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences
Jesus Martin-Fernandez et al.
BMC HEALTH SERVICES RESEARCH (2014)
A Community-Engaged Approach to Quantifying Caregiver Preferences for the Benefits and Risks of Emerging Therapies for Duchenne Muscular Dystrophy
Holly L. Peay et al.
CLINICAL THERAPEUTICS (2014)
Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
Janine A. van Til et al.
PHARMACOECONOMICS (2014)
The use of research evidence on patient preferences in health care decision-making: issues, controversies and moving forward
Carmen D. Dirksen
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)
Patients' preferences for selection of endpoints in cardiovascular clinical trials
Robert D. Chow et al.
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES (2014)
Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study
Carmen D. Dirksen et al.
IMPLEMENTATION SCIENCE (2013)
QUANTITATIVE PATIENT PREFERENCE EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY
Ann-Sylvia Brooker et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2013)
The risks of risk aversion in drug regulation
Hans-Georg Eichler et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review
Susan M. Joy et al.
PHARMACOECONOMICS (2013)
Quantifying Benefit-Risk Preferences for Medical Interventions: An Overview of a Growing Empirical Literature
A. Brett Hauber et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
Fifty years after thalidomide; what role for drug regulators?
Hans-Georg Eichler et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences
Marion Danner et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2011)
Role of patient and public participation in health technology assessment and coverage decisions
Devidas Menon et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Share Paper
